BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Electronic address: andrea.macneill@bccancer.bc.ca. Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Oncol 2018;29:857-71. [PMID: 29432564 DOI: 10.1093/annonc/mdy052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Song H, Ahn JH, Jung Y, Woo JY, Cha J, Chung YG, Lee KH. Intra and extra pelvic multidisciplinary surgical approach of retroperitoneal sarcoma: Case series report. World J Clin Cases 2022; 10(27): 9693-9702 [DOI: 10.12998/wjcc.v10.i27.9693] [Reference Citation Analysis]
2 Sarre-lazcano C, Dumitra S, Fiore M. Pelvic soft tissue sarcomas. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.06.003] [Reference Citation Analysis]
3 Siew CC, Cardona K, van Houdt WJ. Management of recurrent retroperitoneal sarcomas. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.06.008] [Reference Citation Analysis]
4 Danieli M, Swallow CJ, Gronchi A. How to treat liposarcomas located in retroperitoneum. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.04.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Takatsu F, Yamamoto H, Tomioka Y, Tanaka S, Shien K, Suzawa K, Miyoshi K, Otani S, Okazaki M, Sugimoto S, Yamane M, Takahashi K, Toyooka S. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol 2022;20:114. [PMID: 35395855 DOI: 10.1186/s12957-022-02552-y] [Reference Citation Analysis]
6 Schmitz E, Nessim C. Retroperitoneal Sarcoma Care in 2021. Cancers (Basel) 2022;14:1293. [PMID: 35267600 DOI: 10.3390/cancers14051293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Park MT, Kim SD, Han YK, Hyun JW, Lee HJ, Yi JM. Enhancement of Radiosensitivity by DNA Hypomethylating Drugs through Apoptosis and Autophagy in Human Sarcoma Cells. Biomol Ther (Seoul) 2022;30:80-9. [PMID: 34887366 DOI: 10.4062/biomolther.2021.174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Callegaro D, Raut CP, Swallow CJ, Gronchi A. Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program. Curr Opin Oncol 2021;33:301-8. [PMID: 33882525 DOI: 10.1097/CCO.0000000000000746] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Carbone F, Pizzolorusso A, Di Lorenzo G, Di Marzo M, Cannella L, Barretta ML, Delrio P, Tafuto S. Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment. Cancers (Basel) 2021;13:4016. [PMID: 34439171 DOI: 10.3390/cancers13164016] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Willis F, Musa J, Schimmack S, Hinz U, Mechtersheimer G, Uhl M, Schmidt T, Fröhling S, Büchler MW, Schneider M. Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 2021;47:2189-200. [PMID: 33980415 DOI: 10.1016/j.ejso.2021.04.040] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Chamberlain F, Benson C, Thway K, Huang P, Jones RL, Gennatas S. Pharmacotherapy for liposarcoma: current and emerging synthetic treatments. Future Oncol 2021;17:2659-70. [PMID: 33880964 DOI: 10.2217/fon-2020-1092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol 2021. [PMID: 33740198 DOI: 10.1245/s10434-021-09739-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Glasbey JC, Bundred J, Tyler R, Hunt J, Tattersall H, Gourevitch D, Almond LM, Desai AD, Ford SJ. The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma. Eur J Surg Oncol 2021;47:1771-7. [PMID: 33549374 DOI: 10.1016/j.ejso.2021.01.021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Tseng WW, Barretta F, Conti L, Grignani G, Tolomeo F, Albertsmeier M, Angele MK, Rutkowski P, Skoczylas J, De Paoli A, Navarria F, Raut CP, Fairweather M, Farma JM, Nessim C, Goel N, Grignol VP, Ford SJ, Cardona K, Subhawong T, Tattersall HL, Lee RM, Hu JS, Mehren M, Sanfilippo R, Gronchi A. Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer 2021;127:729-38. [DOI: 10.1002/cncr.33323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang Y, Delisle M, Smith D, Srikanthan A. Survival by histology among patients with bone and soft tissue sarcoma who undergo metastasectomy: protocol for a systematic review and meta-analysis. Syst Rev 2020;9:189. [PMID: 32819423 DOI: 10.1186/s13643-020-01445-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Houdt WJ, Fiore M, Barretta F, Rutkowski P, Blay J, Lahat G, Strauss D, Gonzalez RJ, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Schrage Y, Cardona K, Pennacchioli E, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria SP, Canter R, Mullen JT, Callegaro D, Fairweather M, Miceli R, Raut CP, Gronchi A, Gladdy RA. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG. Cancer 2020;126:4917-25. [DOI: 10.1002/cncr.33139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
17 Improta L, Tzanis D, Bouhadiba T, Abdelhafidh K, Bonvalot S. Overview of primary adult retroperitoneal tumours. Eur J Surg Oncol 2020;46:1573-9. [PMID: 32600897 DOI: 10.1016/j.ejso.2020.04.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sarria GR, Petrova V, Wenz F, Abo-Madyan Y, Sperk E, Giordano FA. Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas. Radiat Oncol 2020;15:110. [PMID: 32410696 DOI: 10.1186/s13014-020-01559-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Nessim C, Tzanis D. Is it time for a change in the model of care for AYA patients with soft tissue sarcoma? How to improve outcomes for patients aged 15-25 using a mixed pediatric-adult cancer care model in expert sarcoma centers. Eur J Surg Oncol 2020;46:1201-2. [PMID: 32362467 DOI: 10.1016/j.ejso.2020.03.225] [Reference Citation Analysis]
20 Tian Z, Yang Y, Yang J, Zhang P, Zhang F, Du X, Li C, Wang J. Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study. Cancer Manag Res 2020;12:1339-46. [PMID: 32158266 DOI: 10.2147/CMAR.S237300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Brenneman RJ, Sharifai N, Fischer-Valuck B, Hassanzadeh C, Guzelian J, Chrisinger JSA, Michalski JM, Oppelt P, Baumann BC. Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma. Front Oncol 2019;9:922. [PMID: 31616634 DOI: 10.3389/fonc.2019.00922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
22 Asencio Pascual JM, Fernandez Hernandez JA, Blanco Fernandez G, Muñoz Casares C, Álvarez Álvarez R, Fox Anzorena B, Lozano Borbalas A, Rodriguez Blanco M, Cantin Blázquez S, Artigas Raventós V. Update in pelvic and retroperitoneal sarcoma management: The role of compartment surgery. Cir Esp (Engl Ed) 2019;97:480-8. [PMID: 31521244 DOI: 10.1016/j.ciresp.2019.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Yoshida K, Yoshida M, Haisa M, Yukawa T, Monobe Y, Naomoto Y, Fukazawa T, Yamatsuji T. A case report of left lower lobe segmentectomy for pulmonary metastasis from retroperitoneal liposarcoma. Int J Surg Case Rep 2019;61:169-73. [PMID: 31376737 DOI: 10.1016/j.ijscr.2019.07.059] [Reference Citation Analysis]
24 van Houdt WJ, Raut CP, Bonvalot S, Swallow CJ, Haas R, Gronchi A. New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Current Opinion in Oncology 2019;31:310-6. [DOI: 10.1097/cco.0000000000000535] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
25 Tian Z, Wang X, Liu Z, Wang J, Yao W, Zhao Y, Gao S, Zhang P, Ge H. Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutions. Cancer Manag Res 2019;11:5293-300. [PMID: 31239779 DOI: 10.2147/CMAR.S207150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
26 Bonvalot S, Gaignard E, Stoeckle E, Meeus P, Decanter G, Carrere S, Honore C, Delhorme JB, Fau M, Tzanis D, Causeret S, Gimbergues P, Guillois JM, Meunier B, Le Cesne A, Ducimetiere F, Toulmonde M, Blay JY. Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database. Ann Surg Oncol 2019;26:2286-93. [DOI: 10.1245/s10434-019-07421-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
27 Gage MM, Nagarajan N, Ruck JM, Canner JK, Khan S, Giuliano K, Gani F, Wolfgang C, Johnston FM, Ahuja N. Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget 2019;10:2462-74. [PMID: 31069009 DOI: 10.18632/oncotarget.26809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]